Does hemolysis matter after pulsed field ablation for atrial fibrillation? Insights from the Best Ablate Registry
In our study, PFA for AF was associated with an increase in hemolytic parameters, without significant short-term renal impact or occurrence of clinically significant hemolysis. Hemolysis seems to be influenced by both lesion burden and myocardial injury, highlighting the need for further investigation into the long-term clinical relevance of biomarker-defined hemolysis in PFA-treated patients.
Authors
- Toshinori Chiba (ORCID: https://orcid.org/0000-0002-2173-4519)
- Verena Tscholl (ORCID: https://orcid.org/0000-0003-2748-2540)
- Robert Hättasch (ORCID: https://orcid.org/0000-0001-6276-0847)
- Gerhard Hindricks (ORCID: https://orcid.org/0000-0002-0132-0773)
- Felix Hohendanner (ORCID: https://orcid.org/0000-0002-0194-4615)
- C Baldauf
- Nikolaos Dagres (ORCID: https://orcid.org/0000-0003-0323-4956)
- Alireza Sepehri Shamloo (ORCID: https://orcid.org/0000-0002-4894-8664)
- Philipp Attanasio (ORCID: https://orcid.org/0000-0002-6559-7499)
- Philipp Formum
Institutions
- Deutsches Herzzentrum der Charité (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1016/j.hroo.2025.11.010
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00